Data / Form D filings / Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc.: Form D filings
Theseus Pharmaceuticals, Inc., a pharmaceuticals company in Cambridge, MA, filed 3 Form D notices with the SEC between 2018 and 2021. The latest, on February 4, 2021, reports $95.1 million sold of a $100.1 million offering to 16 investors.
Find out what Theseus Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 210 Broadway, Suite 201, Cambridge, MA, 02139
- Phone
- (212) 739-6493
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1745020
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 4, 2021 | New notice | $100,099,954 | $95,099,957 | $4,999,997 | 16 | Jan 22, 2021 | sec.gov |
| Feb 4, 2021 | Amendment | $22,136,987 | $22,136,987 | $0 | 3 | Jun 14, 2018 | sec.gov |
| Jun 29, 2018 | New notice | $15,000,000 | $5,000,000 | $10,000,000 | 3 | Jun 14, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Iain Dukes | Executive Officer, Director | |
| William C. Shakespeare | Director | |
| Michael C. Rome | Director | |
| Carl C. Gordon | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Feb 1, 2021 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Theseus Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.